| First Author | Hsu MC | Year | 2022 |
| Journal | Int J Mol Sci | Volume | 23 |
| Issue | 4 | PubMed ID | 35216179 |
| Mgi Jnum | J:321624 | Mgi Id | MGI:6886710 |
| Doi | 10.3390/ijms23042064 | Citation | Hsu MC, et al. (2022) Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice. Int J Mol Sci 23(4) |
| abstractText | HLJ1 (also called DNAJB4) is a member of the DNAJ/Hsp40 family and plays an important role in regulating protein folding and activity. However, there is little information about the role of HLJ1 in the regulation of physiological function. In this study, we investigated the role of HLJ1 in blood coagulation using wild-type C57BL/6 mice and HLJ1-null (HLJ1(-/-)) mice. Western blot analysis and immunohistochemistry were used to assess the expression and distribution of HLJ1 protein, respectively. The tail bleeding assay was applied to assess the bleeding time and blood loss. A coagulation test was used for measuring the activity of extrinsic, intrinsic and common coagulation pathways. Thromboelastography was used to measure the coagulation parameters in the progression of blood clot formation. The results showed that HLJ1 was detectable in plasma and bone marrow. The distribution of HLJ1 was co-localized with CD41, the marker of platelets and megakaryocytes. However, genetic deletion of HLJ1 did not alter blood loss and the activity of extrinsic and intrinsic coagulation pathways, as well as blood clot formation, compared to wild-type mice. Collectively, these findings suggest that, although HLJ1 appears in megakaryocytes and platelets, it may not play a role in the function of blood coagulation under normal physiological conditions. |
